Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types, Distribution Channels, Company Analysis
Buy NowGet Free Customization in This Report
The autoinjector is a diagnostic device which is used for the treatment of allergies. It works as the injection which is given at the accurate depth and through which patients feels comfortable comparing to manual syringes. As the autoinjector is a modern developed device, so they are more preferred over conventional devices these days. According to Renub Research analysis, it is predicted that by 2026 the Global Auto Injector Market will be US$ 5.8 Billion.
According to the product basis, autoinjector market is classified by the prefilled and fillable injector. According to usability, the market was categorized into disposable and reusable injectors. The combined growth of these injectors technologically sustains the growth of autoinjectors market globally. The most restraining factors of autoinjector market are the side effects of the drugs, which affects the human intolerance.
The United States allergy is counted as the sixth leading cause of critical cause of chronic illness. North America region held a dominant position in the global auto-injectors market share in 2019. The market in Europe is witnessing increasing shortages of epinephrine auto-injectors following manufacturing issues with the Emerade brand auto-injector. Therefore, critical companies in the market can focus on expanding their presence in the region.
May 2020, the Kaleo Company has relaunched the autoinjector in the Canada. The federal governments of the states were stepping forward for the approvals of the autoinjectors market in the globe. Another imitative taken in Aug 2020 by Antares Pharma and Lunatus has entered in countries like Saudi Arabia and UAE for the distribution of the drugs in the market. Due to the wide spread of the coronovirus virus across the globe, it has affected the supply-chain system of the autoinjectors market globally.
Renub Research report titled “Auto-injectors Market Global Forecast by Regions (North America, Asia Pacific, Europe, Middle East & Africa), Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types (Prefilled, Fillable), Usability (Reusable, Disposable), Distribution Channels (Online Pharmacies, Retail Pharmacies, Others), Companies (Antares Pharma, Mylan N.V, Amgen Inc, Novartis AG, Bayer AG)” studies the global market for autoinjectors and offers a thorough overview of the growth drivers and barriers, industry trends, leading players and their future predictions.
Region - Auto-injectors market has been segmented into North America, Europe, Asia Pacific, and Middle East & Africa
• North America
• Europe
• Asia Pacific
• Middle East & Africa
Application - Global Autoinjectors Market has been segmented by
• Anaphylaxis
• Multiple Sclerosis
• Rheumatoid Arthritis
• Others
Product – Both types of Autoinjectors have studied been studied in the report
• Prefilled
• Fillable
Usability - This report has been studied two points
• Reusable
• Disposable
Distribution Channels
• Online Pharmacies
• Retail Pharmacies
• Others
The Companies in this report have been studied with the following viewpoints
• Company Overview
• Recent Developments
• Financial Insight
Key Players
• Antares Pharma
• Mylan N.V
• Amgen Inc
• Novartis AG
• Bayer AG
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com